Login
From:
Parkinson's News Today
(Uncensored)
subscribe
Phase 1 trial of investigational therapy ALX-001 doses first Parkinson's patient
https://parkinsonsnewstoday.com/news/phase-1-trial-investigational-therapy-alx-001-doses-first-parkinsons-patient/
links
backlinks
Tagged with:
investigational therapy
phase 1 trial
The clinical trial is assessing the safety of Allyx Therapeutics' ALX-001 versus a placebo when given to adults twice daily for 28 days.
Roast topics
Find topics
Find it!
